missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18786489

Human CD45 Alexa Fluor™ 750-conjugated Antibody, R&D Systems™
GREENER_CHOICE

Mouse Monoclonal Antibody

Brand:  R&D Systems FAB14301S-100UG

Product Code. 18786489

  • € 490.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD45 Monoclonal specifically detects CD45 in Human samples. It is validated for Flow Cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD45
Monoclonal
Alexa Fluor 750
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
B220, CD45, CD45 antigen, CD45R, EC 3.1.3.48, LCA, L-CA, LY5, protein tyrosine phosphatase, receptor type, C, PTPRC, receptor-type tyrosine-protein phosphatase C, T200 glycoprotein, T200 leukocyte common antigen, T200receptor type, c polypeptide
Mouse myeloma cell line NS0-derived recombinant human CD45, Thr24-Asn575, Accession No. P08575
100 μg
5788.0
Human
Supernatant
Flow Cytometry
998209
Flow Cytometry 0.25-1 μg/106 cells
P08575
Mouse
Protein A or G purified from hybridoma culture supernatant
Primary
Detects human CD45 in direct ELISAs.
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8°C as supplied.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.